Is Protagonist Therapeutics, Inc. (PTGX) a Buy, Sell, or Hold?
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$131.27 USD
$1.38 (1.06%)
- Volume
- 564.97K
- Average Volume
- 722.65K
- Market Capitalization
- $8.44B
- P/E Ratio
- -72.85
- Dividend Yield
- 0.00%
- Price Target
- $121.00
- Year High
- $141.10
- Year Low
- $50.49
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $17.76
PTGX vs. The Competition
| Properties | PTGX | ACLX | AKRO | ALKS |
|---|---|---|---|---|
| Market Cap | $8.44B | $6.73B | $4.5B | $8.6B |
| Shares Outstanding | $64.31M | $58.51M | $82.32M | $166.68M |
| P/E Ratio | -72.85 | -28.27 | -19.87 | 55.48 |
| EPS | -1.76 | -4.07 | -2.72 | 0.92 |
| Day Low | 128.68 | 115.03 | 54.52 | 50.67 |
| Day high | 131.95 | 115.07 | 54.65 | 52.165 |
| Year Low | 50.485 | 50.85 | 21.34 | 25.17 |
| Year High | 141.1 | 115.13 | 58.4 | 55.67 |
| Average Price 50 | 109.801 | 112.6244 | 53.0613 | 43.408 |
| Average Price 200 | 92.5667 | 84.1487 | 48.19307 | 34.0053 |
| Volume | 564.97K | 13.19M | 11.61M | 1.78M |
| Average Volume | - | - | - | - |